Genetic Testing for Fitness and Nutrition: What It Can and Can't Tell You
Genetic Testing for Fitness and Nutrition: What It Can and Can't Tell You
Genetic testing has a reputation problem. On one end of the spectrum, direct-to-consumer ancestry kits have made DNA data feel casual and inconsequential. On the other, the idea of "reading your genes" carries an implication of determinism — that the results will tell you something fixed and final about your health.
Neither framing is accurate, and neither is useful.
What nutrition and fitness genetic testing actually produces is a map of predispositions. Tendencies. The way your body is inclined to respond to certain inputs — carbohydrates, saturated fat, caffeine, training volume, inflammation triggers — based on the variants present in specific genes. These predispositions are real, measurable, and clinically meaningful. They are not destiny, and they do not override behavior. But they do explain why the same diet produces different results in different people, why some individuals adapt rapidly to endurance training while others plateau, and why generic recommendations built from population averages fit some people well and others poorly.
Understanding your predispositions is not the end of the analysis. It is the beginning.
What fitness and nutrition genetic testing actually tests
The testing used in the Longevity Blueprint is not whole-genome sequencing. It is a targeted panel of single nucleotide polymorphisms — SNPs, pronounced "snips" — which are specific, well-researched points in the genome where individuals commonly differ. Each SNP has been studied for its association with a particular physiological response, and the panel covers the variants with the most robust and replicated evidence behind them.
The panel examines approximately 70 SNPs across six functional categories: macronutrient response, micronutrient utilization, caffeine and alcohol metabolism, inflammation and recovery, cardiovascular predispositions, and exercise response patterns. Each result indicates which variant you carry and what that variant is associated with in the research literature.
What each category tells you
Macronutrient response
Perhaps the most practically relevant category. Research has identified gene variants that influence how individuals respond to different macronutrient distributions — specifically, how they handle higher carbohydrate intake relative to fat, and how saturated fat affects their lipid profiles.
Fat utilization efficiency. Variants near the PPARG and ADIPOQ genes influence fat metabolism and fat cell behavior. Individuals with certain variants appear to respond more favorably to higher-fat dietary approaches — showing better satiety, better fat oxidation, and more stable energy — while others respond better to higher-carbohydrate distributions. This is one mechanism behind why two people following the same macronutrient split have genuinely different outcomes.
Saturated fat and LDL response. The APOE gene — best known for its role in Alzheimer's risk — also has a strong, well-documented effect on how individuals respond to dietary saturated fat. APOE4 carriers tend to show significantly larger LDL increases in response to high saturated fat intake than APOE3 or APOE2 carriers. Knowing your APOE status changes what dietary fat intake actually means for your cardiovascular risk — a distinction that gets missed entirely when nutritional guidance is applied generically.
Carbohydrate tolerance. Variants in the AMY1 gene influence salivary amylase production — the enzyme that begins carbohydrate digestion in the mouth. Higher copy numbers of AMY1 are associated with more efficient starch digestion and better blood sugar regulation in response to carbohydrate-rich meals. Lower copy numbers are associated with greater blood sugar volatility from the same meals.
Micronutrient utilization
Several well-studied gene variants affect how efficiently the body converts, absorbs, and uses specific vitamins and minerals. These variants don't cause deficiency on their own, but they do mean that the same dietary intake or supplement dose produces different outcomes in different individuals.
MTHFR and folate metabolism. The MTHFR gene encodes an enzyme critical for converting dietary folate into its active form. The C677T variant — carried in some form by roughly half the population — reduces this enzyme's efficiency. Individuals with the homozygous variant (two copies) may have significantly impaired folate conversion, which affects methylation, homocysteine regulation, and cellular repair processes. Standard folate intake may be insufficient; methylated folate (5-MTHF) is the relevant form for MTHFR variants.
VDR and vitamin D. Variants in the vitamin D receptor gene influence how effectively cells respond to vitamin D. Two people with identical serum 25-OH vitamin D levels can have meaningfully different vitamin D activity depending on their VDR variant. This is one reason why some individuals remain symptomatic for vitamin D-related issues despite "normal" blood levels.
GC gene and vitamin D binding. The GC gene encodes the protein that transports vitamin D through the bloodstream. Certain variants reduce transport efficiency, meaning that serum vitamin D levels may understate functional vitamin D status — a nuance invisible to bloodwork alone.
Caffeine and alcohol metabolism
These categories are practical in ways that extend beyond lifestyle curiosity.
Caffeine metabolism (CYP1A2). The CYP1A2 gene controls the enzyme primarily responsible for metabolizing caffeine in the liver. Individuals with the fast-metabolizer variant clear caffeine significantly more quickly than slow metabolizers. For slow metabolizers, afternoon caffeine consumption has a measurably larger effect on sleep quality and cortisol levels — and the performance benefits of caffeine before exercise are blunted by its longer half-life and associated side effects. For fast metabolizers, higher caffeine intake is generally better tolerated and may provide more consistent ergogenic benefit.
Alcohol metabolism (ADH1B, ALDH2). Variants in alcohol dehydrogenase genes influence how quickly ethanol is converted to acetaldehyde (the toxic intermediate) and then to acetate (the cleared form). Slow conversion to acetate — the ALDH2*2 variant, common in East Asian populations — causes the "flush response" and is associated with significantly higher cancer risk from alcohol consumption even at moderate intake levels. This is a variant worth knowing.
Inflammation and recovery
IL-6 and TNF-alpha variants. Interleukin-6 and tumor necrosis factor-alpha are central mediators of the inflammatory response to training stress. Variants in the genes encoding these cytokines influence the magnitude and duration of post-exercise inflammation. Individuals with higher inflammatory response variants tend to need longer recovery between high-intensity sessions and are at higher risk for overtraining if pushed on a standard schedule. Identifying this predisposition changes how training should be periodized — more recovery time is not a weakness, it is a physiological requirement.
COL5A1 and connective tissue. Variants in this collagen gene are associated with connective tissue stiffness and injury risk — specifically, higher rates of Achilles tendinopathy and anterior cruciate ligament injury. This finding doesn't mean an injury is inevitable; it means that connective tissue loading should be progressed more conservatively and that preventive prehabilitation work carries a higher priority.
Exercise response patterns
ACTN3 and muscle fiber composition. The ACTN3 gene encodes alpha-actinin-3, a protein found exclusively in fast-twitch (Type II) muscle fibers. The R577X variant produces a non-functional version of the protein. Individuals with two copies of the X variant (XX genotype) have no functional alpha-actinin-3 — and as a result, tend to have a higher proportion of slow-twitch fibers, better endurance characteristics, and a less pronounced power response to strength training. RR individuals tend toward more explosive power expression. This doesn't determine athletic potential — it informs which training stimuli a given physiology responds to most efficiently.
VO₂ max trainability. Variants in the PPARGC1A gene — which encodes a protein central to mitochondrial biogenesis — are associated with differences in how rapidly VO₂ max responds to aerobic training. High-responder variants show greater cardiorespiratory adaptation for the same training volume. Lower-responder variants require more consistent, higher-volume training to produce equivalent gains. This is a meaningful input for structuring a training program and setting realistic expectations for the timeline of cardiovascular improvement.
What genetic testing cannot tell you
This is the section that most genetic testing marketing omits, and it is the most important one for using results correctly.
Genetic predispositions are tendencies, not outcomes. An APOE4 variant raises Alzheimer's risk in population studies. It does not mean you will develop Alzheimer's. A high-inflammation IL-6 variant increases your recovery demands. It does not mean you will overtrain. These are probabilistic associations derived from large groups. They describe what tends to happen, not what will happen to you specifically.
Lifestyle factors outweigh most genetic variants in magnitude. The effect size of most nutrition and fitness SNPs is real but modest. Training consistently, eating a diet with adequate protein and micronutrient density, managing sleep and stress, and maintaining a healthy body composition have larger effects on the outcomes these genes influence than the variant itself does. Genetic results should sharpen how you do those things — not replace doing them.
Genetic data does not tell you your current state. A predisposition to vitamin D insufficiency tells you nothing about your actual vitamin D level today. A carbohydrate metabolism variant says nothing about your current fasting glucose or insulin sensitivity. Genetics describes the terrain. Bloodwork, DEXA, and VO₂ max testing measure where you are on that terrain right now. Both layers are necessary, and they are not substitutes for each other.
This is not clinical genetic testing. Nutrition and fitness panels do not sequence medically actionable disease genes. They are not diagnostic tools for hereditary conditions, carrier status, or clinical genetic risk. For those conversations, a genetic counselor and a clinical genetic test are the appropriate path.
How genetic data integrates with the other Blueprint tests
The most useful way to think about genetic testing is as the fixed layer of a four-layer picture.
Your genetics describe your predispositions — what your body is inclined to do in response to various inputs. They don't change. Your DEXA scan, VO₂ max test, and bloodwork describe your current state — what your body is actually doing right now. Those do change, in response to training, nutrition, sleep, stress, and time.
Knowing both layers together produces a more precise set of decisions. An MTHFR variant alongside elevated homocysteine in your bloodwork is a more actionable finding than either one alone. A low VO₂ max trainability variant alongside a below-average VO₂ max score tells you the timeline for improvement should be set with patience rather than urgency. High visceral fat on a DEXA scan in someone with an unfavorable APOE genotype sharpens the priority of addressing it.
Predisposition explains what you're working with. Measurement tells you what you've done with it. The gap between the two is where the plan lives.
Getting tested in San Francisco
Genetic testing at Custom Fit is done via a simple buccal swab — a cheek swab completed on-site in under five minutes. Results take two to three weeks and are reviewed with a registered dietitian as part of your Longevity Blueprint consultation, where genetic findings are interpreted alongside your DEXA, VO₂ max, and bloodwork results.
Standalone genetic testing is available for those who have already completed other components. The panel covers approximately 70 SNPs across nutrition, fitness, metabolism, and recovery categories.
Learn more about genetic testing or see how it fits into the complete Longevity Blueprint.
Nutrition and fitness genetic testing at Custom Fit is not a clinical genetic test and is not intended for medical diagnosis, disease risk prediction, or carrier screening. Results are for health and performance optimization purposes. Consult a genetic counselor or physician for clinical genetic concerns.